Annie Olivier

<i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor

Laurent Hennequin, J M Allen, J. Breed et al. · Journal of Medicinal Chemistry · 2006 · 367 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket

Peter Ballard, Robert H. Bradbury, Craig S. Harris et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors

Catherine Bardelle, Bernard Barlaam, Nigel Brooks et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase

Peter Ballard, Robert H. Bradbury, Laurent Hennequin et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino)quinazolines as potent and selective c-Src kinase inhibitors

Bernard Barlaam, Mike Fennell, Hervé Germain et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 28 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14